1. Home
  2. SPHL vs EVOK Comparison

SPHL vs EVOK Comparison

Compare SPHL & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPHL
  • EVOK
  • Stock Information
  • Founded
  • SPHL 2002
  • EVOK 2007
  • Country
  • SPHL Singapore
  • EVOK United States
  • Employees
  • SPHL N/A
  • EVOK N/A
  • Industry
  • SPHL Homebuilding
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPHL Consumer Discretionary
  • EVOK Health Care
  • Exchange
  • SPHL Nasdaq
  • EVOK Nasdaq
  • Market Cap
  • SPHL 6.0M
  • EVOK 5.4M
  • IPO Year
  • SPHL 2024
  • EVOK 2013
  • Fundamental
  • Price
  • SPHL $0.43
  • EVOK $5.40
  • Analyst Decision
  • SPHL
  • EVOK
  • Analyst Count
  • SPHL 0
  • EVOK 0
  • Target Price
  • SPHL N/A
  • EVOK N/A
  • AVG Volume (30 Days)
  • SPHL 49.1K
  • EVOK 479.3K
  • Earning Date
  • SPHL 01-01-0001
  • EVOK 08-14-2025
  • Dividend Yield
  • SPHL N/A
  • EVOK N/A
  • EPS Growth
  • SPHL N/A
  • EVOK N/A
  • EPS
  • SPHL N/A
  • EVOK N/A
  • Revenue
  • SPHL $6,456,601.00
  • EVOK $12,794,859.00
  • Revenue This Year
  • SPHL N/A
  • EVOK $57.38
  • Revenue Next Year
  • SPHL N/A
  • EVOK $59.57
  • P/E Ratio
  • SPHL N/A
  • EVOK N/A
  • Revenue Growth
  • SPHL N/A
  • EVOK 70.02
  • 52 Week Low
  • SPHL $0.35
  • EVOK $1.94
  • 52 Week High
  • SPHL $7.80
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • SPHL 42.26
  • EVOK 51.66
  • Support Level
  • SPHL $0.39
  • EVOK $5.10
  • Resistance Level
  • SPHL $0.56
  • EVOK $5.70
  • Average True Range (ATR)
  • SPHL 0.06
  • EVOK 0.49
  • MACD
  • SPHL -0.00
  • EVOK -0.08
  • Stochastic Oscillator
  • SPHL 31.27
  • EVOK 28.36

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: